A commitment to excellence

About Merz

Merz North America is a specialty healthcare company that develops and commercializes innovative treatment solutions in aesthetics, dermatology and neurosciences in the U.S. and Canada.  Our ambition is to become a recognized leader in the treatment of movement disorders, and in aesthetics and dermatology. Our future is promising, and we are committed to advancing new therapeutic options and improving patients’ lives.

For more than 100 years, the development of our products has been based on Merz`s commitment to providing innovative medical approaches that earn trust of patients, physicians and partners worldwide. Globally, the companies of Merz Pharma Group are focused on medications for treating neurological and psychiatric illnesses, and they have assumed a leading role in the field of Alzheimer’s disease research.  Founded in 1908, Merz Pharma Group is a privately owned company headquartered in Frankfurt, Germany.

Meet our North America leadership team

Bill Humphries
President and CEO
Merz North America, Inc.

John Donofrio
Chief Financial Officer
Head – North American
Business Development

Jim Hartman
Vice President
Merz Aesthetics Marketing

Glenn Block
Vice President and Head
U.S. Neurosciences

Patrick Urban
Vice President
Merz Aesthetics Sales

David Dobrowski
Vice President and Head
North American Research and Development

Brian Pilcher, PhD
Vice President
U.S. Medical Affairs

Bill Edwards, JD
Vice President
General Counsel

Salisa Hauptmann
Vice President
Chief Compliance Officer

Hyunna Coelho
Vice President
CORE Services

Bob Bennett
President and General
Manager
Merz Pharma Canada, Ltd.

Stefan Schacht, PhD
Vice President
Corporate Strategic Sourcing & Corporate IT

Matt Anderson
Vice President
Technical Operations

Philippe Adams
Vice President
Managed Markets & Customer Solutions

David Dobrowski
Vice President and Head
North American Research and Development

David joined Merz in March 2011 and currently serves as Vice President and Head of North American Research and Development. In this role, he is responsible for all medical, regulatory and product safety functions for Merz in North America. He leads the planning and execution of all clinical and pre-clinical development programs in North America and serves as the Global lead on all of Merz‘s research and development activities relating to medical dermatology. He brings more than 23 years of experience in the pharmaceutical and medical device space and holds a Bachelor of Science degree from University of North Carolina at Wilmington. David is a member of the Regulatory Affairs Professional Society (RAPS), Drug Information Association (DIA) and the North Carolina Regulatory Affairs Forum (NCRAF).

Philippe Adams
Vice President
Managed Markets & Customer Solutions

Philippe joined Merz in December 2015 as Vice President – Managed Markets & Customer Solutions.  In this role, he is primarily responsible for developing Merz’s North American market access and reimbursement strategy to enhance patient access to Merz prescription products.  Philippe has deep knowledge and experience across numerous categories in the areas of payer contract negotiation, reimbursement, market access, government accounts and patient assistance programs, and he has a proven track record of establishing and leading all facets of Managed Markets from strategy development to field execution and implementation across all channels.  Philippe came to Merz from Valeant Pharmaceuticals with more than 20 years of experience in the pharmaceutical industry.  He holds a Bachelor of Science degree  from Purdue University and a Master of Business Administration degree from the Quinlan School of Business at Loyola University Chicago.  He is based in Merz’s North American headquarters in Raleigh, North Carolina.

Patrick Urban
Vice President
Merz Aesthetics Sales

Patrick Urban currently serves as Vice President and US Head of Sales for Merz Aesthetics.  In this role, Patrick is responsible for leading the sales of the Aesthetics portfolio including device, injectables and professional skincare. Patrick brings 22 years of commercial experience in the U.S. pharmaceutical and medical device industries.   Patrick holds a Bachelor‘s degree in Marketing from Bloomsburg University in Pennsylvania and earned his MBA at Loyola College in Baltimore, Maryland.  He is based in Merz’s North American headquarters in Raleigh, North Carolina.

Salisa Hauptmann
Vice President
Chief Compliance Officer

Salisa joined Merz in March 2015 as Vice President and Chief Compliance Officer. In this role, she is responsible for providing strategic and operational leadership to Merz on matters relating to compliance issues, including industry standards established by the Department of Health and Human Services, the Office of Inspector General, and other Federal and state agencies. Prior to joining Merz, Salisa served as Vice President, Global Regulatory Affairs – Emerging Markets, Asia Pacific and Europe for GlaxoSmithKline. She brings more than 20 years of pharmaceutical regulatory and compliance experience to her current role. Her career includes time spent at Stiefel Laboratories and Novartis, and she has a breadth of experience across multiple specialties, including dermatology, neurology, oncology and respiratory disorders. Hauptmann holds a Bachelor of Science degree from University of California, Davis; she earned her Master of Public Health degree at Webster University in St. Louis, Missouri.

Matt Anderson
Vice President
Technical Operations

Matt joined Merz in August 2011 as Vice President, Quality Operations & Business Excellence and currently serves as Vice President – Technical Operations. In this role, he is primarily accountable for manufacturing operations, supply chain management for Merz in the U.S. and quality operations globally. Prior to joining Merz, he served as Corporate Quality Director and Management Representative for Baxter’s Global Purchasing and Supply Chain organizations. Matt has more than 20 years of experience within the biomedical, pharmaceutical and medical device industries. He has been certified as a Quality Engineer, Six Sigma Green Belt, and as an ISO Lead Auditor for Medical Devices. Matt holds a Bachelor of Science degree in Molecular Biology and Pre-Health from the University of Wisconsin Parkside and studied Total Quality Management at the graduate level at Marquette University.

Stefan Schacht, PhD
Vice President
Corporate Strategic Sourcing & Corporate IT

Stefan joined Merz Pharma Group in January 2007 and serves as Global Vice President – Corporate IT and Corporate Sourcing. In July 2014, Stefan transferred to the U.S., to assume leadership of Corporate IT Americas, in addition to his responsibilities within the Merz Global organization. In this interim role, Stefan will lead the coordination and enhancement of Merz’s IT processes and infrastructure in the Americas, ensuring alignment with global IT strategy. In addition, Stefan will continue to oversee life cycle management of vendors and execute sourcing tools in order to achieve global solutions. Stefan has more than 14 years of experience in information technology and supply chain management, with more than 8 of those years focused on strategic sourcing. Prior to joining Merz Pharma Group, Stefan served as Head for Supply Chain Management and Knowledge Management for Corporate Center of Degussa AG. Stefan holds a PhD from the Institute for Inorganic and Analytical Chemistry at University Frankfurt am Main and University of Santa Barbara.

John Donofrio
Chief Financial Officer
Head – North American
Business Development

Bob Bennett
President and General
Manager
Merz Pharma Canada, Ltd.

Bob Bennett currently serves as President and General Manager – Merz Pharma Canada, Ltd. Bob joined Merz in September 2008 as Director of Marketing and Sales, Canada, and most recently served as Business Unit Director – Aesthetics/OTC. He brings more than 25 years of pharmaceutical sales and marketing experience to his role as head of Merz’s Canadian business. Bob holds a Bachelor’s degree in Economics from Wilfrid Laurier University.

Bill Humphries
President and CEO
Merz North America, Inc.

Bill joined Merz as President and Chief Executive Officer (CEO) of Merz North America in March of 2012. He is a member of the Merz Pharma Board and chairman of the Merz Pharmaceuticals LLC Board, Merz Aesthetics Board, and the Merz Canada Board. As President and CEO, Bill develops and implements overall strategies, manages operations, evaluates financial growth, and enhances the ethical culture of the company. Bill has more than 25 years of experience in the specialty pharmaceutical industry, with more than 22 of those years focused on the commercialization of dermatology specialty pharmaceutical products. He received a Master of Business Administration from Pepperdine University. Bill earned a Bachelor of Arts degree for his undergraduate studies at Bucknell University.

Brian Pilcher, PhD
Vice President
U.S. Medical Affairs

Brian joined Merz in December 2004 and serves as Vice President of Medical Affairs for Merz North America. Brian is primarily responsible for leading the Medical Affairs function serving Aesthetics, Dermatology, and Neuroscience businesses, which includes Field Clinical Specialist, Regional Medical Manager, Aesthetics Clinical Services, all Scientific and Medical Communications, Physician Relations, and Thought Leader Development, as well as all grants and sponsorship administration in the US. Brian has over 15 years of experience in medical research and education. Brian completed his doctoral studies at the University of Oklahoma, earning a PhD in Cell Biology.

Jim Hartman
Vice President
Merz Aesthetics Marketing

Jim Hartman currently serves as Vice President and US Head of Marketing for Aesthetics & OTC. In this role, Jim leads the strategic development, marketing and commercial implementation for the Aesthetics & OTC portfolio including device, injectables and skincare.  His role acts as a leading conduit between the commercial strategy and needs for success in the US and our Global Project Teams for aesthetics. He has more than 24 years of experience in the pharmaceutical industry, with more than 15 of those years focused on the development and marketing of specialty pharmaceutical products. Jim holds a Bachelor of Arts degree in Social Science from the University of California, Irvine. He is based in Merz’s North American headquarters in Raleigh, North Carolina.

Bill Edwards, JD
Vice President
General Counsel

Bill joined Merz in March 2009 as Vice President & General Counsel. In October of 2012, Bill was selected to lead the Company’s legal function in the US. In addition, Bill continues to serve as General Counsel, Vice President, and Secretary of the parent/holding company of Merz Pharmaceuticals, LLC, and Merz Aesthetics, Inc. Bill has over 23 years of experience providing legal counsel to pharmaceutical companies and to diverse components of the US healthcare delivery system. Bill holds his Juris Doctor and Master of Social Work from the University of North Carolina at Chapel Hill, where he was an editor of the North Carolina Law Review. He received a Bachelor or Arts degree from the University of Virginia. Bill is a member of the North Carolina Bar.

Hyunna Coelho
Vice President
CORE Services

Hyunna joined Merz in November 2009 and currently serves as Vice President of CORE Services. As part of CORE Services, Hyunna leads: Corporate Communications; Commercial Analytics; Operations; Industry and Convention Services; Human Resources; Training and Development; Organizational Development; and Production, Media & Events. She has more than 27 years of experience in the healthcare industry, with more than 14 of those years focused on sales training and development and commercial operations in specialty pharmaceuticals. Hyunna holds a Master of Business Administration in Pharmaceutical Marketing from St. Joseph’s University in Philadelphia, Pennsylvania. She obtained her Bachelor of Science degree from the University of South Carolina.

Glenn Block
Vice President and Head
U.S. Neurosciences

Glenn joined Merz in August 2007 and currently serves as Vice President and Head – U.S. Neurosciences. Prior to this, Glenn held the role of President and General Manager of Merz Pharma Canada Ltd. and holds the distinction of having built Merz’s Canadian organization from the ground up. Glenn has over 20 years of experience in the pharmaceutical industry, with most of those years focused on the development and marketing of neurotoxins in North America. Glenn holds an Honors Bachelor of Commerce degree from Queen’s University in Kingston, Ontario.